Search Results

In this episode presented by Element Materials Technology, BioSpace’s head of insights discusses how China, historically focused on manufacturing, is increasingly becoming an innovation leader, particularly in pharmaceuticals, with guests Dr. Jihye Jang-Lee and Dr. Khanh Courtney. Ultimately, balanced strategies involve domestic capacity investments coupled with global collaboration.

New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations

Some observers see risks to becoming over-reliant on local facilities, noting the potential need for trade partners if domestic production is disrupted.

In this discussion, our guests give their observations and recommendations on how companies can navigate within the United States market and beyond. Watch now.

Industry leaders are focused on the resilience of key starting material supply and the knock-on effects of automation in the new year.

When talking to some of the most impressive women in biopharma, the conversation inevitably turned to what these women wanted other entrepreneurs to know. Here’s the best of the best of that advice.